Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03944915
Title De-Escalation Therapy for Human Papillomavirus Negative Disease (DEPEND)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Chicago

pharynx squamous cell carcinoma

head and neck squamous cell carcinoma

oral squamous cell carcinoma

laryngeal squamous cell carcinoma


Carboplatin + Nivolumab + Paclitaxel

Cisplatin + Filgrastim + Fluorouracil + Hydroxyurea + Paclitaxel

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.